Regenxbio
Price & Volume
Stats
See more52W Range | $6.89-$16.19 |
Market Cap | $463M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $170.4M |
Revenue Growth (YoY) | 43% |
Gross Profit (12 Mos) | -$78.1M |
Diluted EPS | -$3.76 |
News
See moreYahoo Finance • 19 days ago
Levi & Korsinsky, LLP: RGNX Disclosure Timeline Reveals Pattern of Alleged Investor Harm
Yahoo Finance • 20 days ago
REGENXBIO DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages REGENXBIO, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - RGNX
Yahoo Finance • 23 days ago
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
About
CEO | Mr. Curran M. Simpson M.S. |
CFO | Mr. Mitchell Chan M.B.A. |
Address | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 371 |